Quick Answer
NEUROONE MEDICAL TECHNOLOGIES Corp reported Total Revenue of $9.10 million for the year ending 2025.
- NEUROONE MEDICAL TECHNOLOGIES Corp showed an increase of +163.5% in Total Revenue from 2024 to 2025.
- This data is from NEUROONE MEDICAL TECHNOLOGIES Corp's annual report (Form 10-K), filed with the SEC on December 17, 2025.
- XBRL data for this metric is available from 2010 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2011: $3.1 thousand | Q3 2011: $812.00 | Q1 2012: $147.00 | Q3 2012: $23.00 | Q1 2013: $406.00 | Q4 2020: $71.5 thousand | Q1 2021: $18.2 thousand | Q2 2021: $40.1 thousand | Q4 2021: $33.7 thousand | Q1 2022: $36.6 thousand | Q2 2022: $32.0 thousand | Q4 2022: $114.6 thousand | Q1 2023: $466.2 thousand | Q2 2023: $629.9 thousand | Q4 2023: $977.6 thousand | Q1 2024: $1.38 million | Q2 2024: $825.8 thousand | Q4 2024: $3.27 million | Q1 2025: $1.39 million | Q2 2025: $1.70 million | Q4 2025: $2.89 million.
- Over the full 8 years of available data (2010 to 2025), NEUROONE MEDICAL TECHNOLOGIES Corp's Total Revenue has grown by 779,479.4%.
- Historical annual values: Fiscal year 2025: $9.10 million | Fiscal year 2024: $3.45 million | Fiscal year 2023: $1.95 million | Fiscal year 2022: $171.2 thousand | Fiscal year 2021: $178.1 thousand | Fiscal year 2012: $921.00 | Fiscal year 2011: $5.4 thousand | Fiscal year 2010: $1.2 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: